Global Overactive Bladder (OAB) Therapeutics Market Research Report 2024(Status and Outlook)

Global Overactive Bladder (OAB) Therapeutics Market Research Report 2024(Status and Outlook)



Report Overview:

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.

The Global Overactive Bladder (OAB) Therapeutics Market Size was estimated at USD 5251.78 million in 2023 and is projected to reach USD 6054.89 million by 2029, exhibiting a CAGR of 2.40% during the forecast period.

This report provides a deep insight into the global Overactive Bladder (OAB) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Overactive Bladder (OAB) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Overactive Bladder (OAB) Therapeutics market in any manner.

Global Overactive Bladder (OAB) Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Allergan

Astellas Pharma

Hisamitsu Pharmaceutical

Pfizer

Ferring

GlaxoSmithKline

Ion Channel Innovations

Kwang Dong Pharmaceutical

Lanzhou Institute of Biological Products

Merck

ONO Pharmaceutical

Sanofi

Tengion

Teva Pharmaceutical Industries

Market Segmentation (by Type)

Anticholinergic Agents

Beta-3 Adrenoreceptor Agonists

Market Segmentation (by Application)

Hosptial

Clinci

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Overactive Bladder (OAB) Therapeutics Market

Overview of the regional outlook of the Overactive Bladder (OAB) Therapeutics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Overactive Bladder (OAB) Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Overactive Bladder (OAB) Therapeutics
1.2 Key Market Segments
1.2.1 Overactive Bladder (OAB) Therapeutics Segment by Type
1.2.2 Overactive Bladder (OAB) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Overactive Bladder (OAB) Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Overactive Bladder (OAB) Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Overactive Bladder (OAB) Therapeutics Market Competitive Landscape
3.1 Global Overactive Bladder (OAB) Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Overactive Bladder (OAB) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Overactive Bladder (OAB) Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Overactive Bladder (OAB) Therapeutics Sales Sites, Area Served, Product Type
3.6 Overactive Bladder (OAB) Therapeutics Market Competitive Situation and Trends
3.6.1 Overactive Bladder (OAB) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Overactive Bladder (OAB) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Overactive Bladder (OAB) Therapeutics Industry Chain Analysis
4.1 Overactive Bladder (OAB) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Overactive Bladder (OAB) Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Overactive Bladder (OAB) Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Overactive Bladder (OAB) Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Overactive Bladder (OAB) Therapeutics Price by Type (2019-2024)
7 Overactive Bladder (OAB) Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Overactive Bladder (OAB) Therapeutics Market Sales by Application (2019-2024)
7.3 Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Overactive Bladder (OAB) Therapeutics Sales Growth Rate by Application (2019-2024)
8 Overactive Bladder (OAB) Therapeutics Market Segmentation by Region
8.1 Global Overactive Bladder (OAB) Therapeutics Sales by Region
8.1.1 Global Overactive Bladder (OAB) Therapeutics Sales by Region
8.1.2 Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Overactive Bladder (OAB) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Overactive Bladder (OAB) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Overactive Bladder (OAB) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Overactive Bladder (OAB) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Allergan
9.1.1 Allergan Overactive Bladder (OAB) Therapeutics Basic Information
9.1.2 Allergan Overactive Bladder (OAB) Therapeutics Product Overview
9.1.3 Allergan Overactive Bladder (OAB) Therapeutics Product Market Performance
9.1.4 Allergan Business Overview
9.1.5 Allergan Overactive Bladder (OAB) Therapeutics SWOT Analysis
9.1.6 Allergan Recent Developments
9.2 Astellas Pharma
9.2.1 Astellas Pharma Overactive Bladder (OAB) Therapeutics Basic Information
9.2.2 Astellas Pharma Overactive Bladder (OAB) Therapeutics Product Overview
9.2.3 Astellas Pharma Overactive Bladder (OAB) Therapeutics Product Market Performance
9.2.4 Astellas Pharma Business Overview
9.2.5 Astellas Pharma Overactive Bladder (OAB) Therapeutics SWOT Analysis
9.2.6 Astellas Pharma Recent Developments
9.3 Hisamitsu Pharmaceutical
9.3.1 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
9.3.2 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
9.3.3 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Market Performance
9.3.4 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics SWOT Analysis
9.3.5 Hisamitsu Pharmaceutical Business Overview
9.3.6 Hisamitsu Pharmaceutical Recent Developments
9.4 Pfizer
9.4.1 Pfizer Overactive Bladder (OAB) Therapeutics Basic Information
9.4.2 Pfizer Overactive Bladder (OAB) Therapeutics Product Overview
9.4.3 Pfizer Overactive Bladder (OAB) Therapeutics Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Ferring
9.5.1 Ferring Overactive Bladder (OAB) Therapeutics Basic Information
9.5.2 Ferring Overactive Bladder (OAB) Therapeutics Product Overview
9.5.3 Ferring Overactive Bladder (OAB) Therapeutics Product Market Performance
9.5.4 Ferring Business Overview
9.5.5 Ferring Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Basic Information
9.6.2 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Product Overview
9.6.3 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Ion Channel Innovations
9.7.1 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Basic Information
9.7.2 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Product Overview
9.7.3 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Product Market Performance
9.7.4 Ion Channel Innovations Business Overview
9.7.5 Ion Channel Innovations Recent Developments
9.8 Kwang Dong Pharmaceutical
9.8.1 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
9.8.2 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
9.8.3 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Market Performance
9.8.4 Kwang Dong Pharmaceutical Business Overview
9.8.5 Kwang Dong Pharmaceutical Recent Developments
9.9 Lanzhou Institute of Biological Products
9.9.1 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Basic Information
9.9.2 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Product Overview
9.9.3 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Product Market Performance
9.9.4 Lanzhou Institute of Biological Products Business Overview
9.9.5 Lanzhou Institute of Biological Products Recent Developments
9.10 Merck
9.10.1 Merck Overactive Bladder (OAB) Therapeutics Basic Information
9.10.2 Merck Overactive Bladder (OAB) Therapeutics Product Overview
9.10.3 Merck Overactive Bladder (OAB) Therapeutics Product Market Performance
9.10.4 Merck Business Overview
9.10.5 Merck Recent Developments
9.11 ONO Pharmaceutical
9.11.1 ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
9.11.2 ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
9.11.3 ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Market Performance
9.11.4 ONO Pharmaceutical Business Overview
9.11.5 ONO Pharmaceutical Recent Developments
9.12 Sanofi
9.12.1 Sanofi Overactive Bladder (OAB) Therapeutics Basic Information
9.12.2 Sanofi Overactive Bladder (OAB) Therapeutics Product Overview
9.12.3 Sanofi Overactive Bladder (OAB) Therapeutics Product Market Performance
9.12.4 Sanofi Business Overview
9.12.5 Sanofi Recent Developments
9.13 Tengion
9.13.1 Tengion Overactive Bladder (OAB) Therapeutics Basic Information
9.13.2 Tengion Overactive Bladder (OAB) Therapeutics Product Overview
9.13.3 Tengion Overactive Bladder (OAB) Therapeutics Product Market Performance
9.13.4 Tengion Business Overview
9.13.5 Tengion Recent Developments
9.14 Teva Pharmaceutical Industries
9.14.1 Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Basic Information
9.14.2 Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Product Overview
9.14.3 Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Product Market Performance
9.14.4 Teva Pharmaceutical Industries Business Overview
9.14.5 Teva Pharmaceutical Industries Recent Developments
10 Overactive Bladder (OAB) Therapeutics Market Forecast by Region
10.1 Global Overactive Bladder (OAB) Therapeutics Market Size Forecast
10.2 Global Overactive Bladder (OAB) Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Overactive Bladder (OAB) Therapeutics Market Size Forecast by Region
10.2.4 South America Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Overactive Bladder (OAB) Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Overactive Bladder (OAB) Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Overactive Bladder (OAB) Therapeutics by Type (2025-2030)
11.1.2 Global Overactive Bladder (OAB) Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Overactive Bladder (OAB) Therapeutics by Type (2025-2030)
11.2 Global Overactive Bladder (OAB) Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings